Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-457-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes
Test material
- Reference substance name:
- Reaction mass of N-butylphosphorothioic triamide and N-propylphosphorothioic triamide
- EC Number:
- 700-457-2
- Molecular formula:
- Unspecified
- IUPAC Name:
- Reaction mass of N-butylphosphorothioic triamide and N-propylphosphorothioic triamide
- Details on test material:
- - Name of test material (as cited in study report): LIMUS-Sambaydestillation
- Test substance No.: 07/0684-1
- Batch identification: 8712 / 062
- Analytical purity: 87 %
- Storage condition of test material: At ambient temperature.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany.
- Age at study initiation: Females were approximately 12 weeks.
- Weight at study initiation: animals of comparable seize and weight
- Housing: individually after mating
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: At least 5 days prior to mating
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.0 ± 3.0ºC
- Humidity (%): 40-70 %
- Air changes (per hr): 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 1% (w/w) carboxymethyl cellulose in water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Formulations (w/w) were prepared daily within 6 hours prior to dosing and were homogenized to a visually acceptable level.
No adjustment was made for specific gravity of the test substance, vehicle, and/or formulation
VEHICLE
- Justification for use and choice of vehicle (if other than water): Based on information provided by Sponsor and trial formulations performed
at NOTOX B.V. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Analyses were conducted once during the treatment phase (30 August 2010), according to a validated
method (NOTOX Project 494646, BASF Project 05Y0684/07X011). Samples of formulations were
analyzed for homogeneity (Groups 2 and 4) and accuracy (Groups 1-4) of preparation. Stability in
vehicle over 6 hours at room temperature was also determined (Groups 2 and 4).
The accuracy of preparation was considered acceptable if the mean measured concentrations were
85-115% of the target concentration. Homogeneity was demonstrated if the coefficient of variation was
≤ 10%. Formulations were considered stable if the relative difference before and after storage was
maximally 10%. - Details on mating procedure:
- - Impregnation procedure: [cohoused]
- If cohoused:
- M/F ratio per cage: 1/1
- Length of cohabitation: no data
- Further matings after two unsuccessful attempts: no data
- Verification of same strain and source of both sexes: [yes]
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0] of pregnancy - Duration of treatment / exposure:
- From Days 6 to 19 post-coitum, inclusive.
- Frequency of treatment:
- daily
- Duration of test:
- until day 20 post-coitum
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 30, 100, 300 mg/kg bw/day
Basis:
nominal conc.
- No. of animals per sex per dose:
- 22
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: the doses were selected based on the available 28-day study
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: At least twice daily. Animals showing pain, distress or discomfort, which was considered not transient in nature or was likely to become more severe, were sacrificed for humane reasons based on OECD guidance document on humane endpoints
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: At least once daily from Day 0 post-coitum onwards. The time of onset, degree and duration was recorded. All symptoms were graded according to fixed scales:
Maximum grade 1: grade 0 = absent, grade 1 = present.
Maximum grade 3 or 4: grade 1 = slight, grade 2 = moderate, grade 3 = severe, grade 4 = very severe.
Examination of cage debris of pregnant females revealed no signs of abortion or premature birth.
BODY WEIGHT: Yes
- Time schedule for examinations: Days 0, 3 and 6-20 (daily) post-coitum.
FOOD CONSUMPTION: Yes
Days 0-3, 3-6, 6-9, 9-12, 12-15, 15-17 and 17-20 post-coitum.
WATER CONSUMPTION: Yes
Subjective appraisal was maintained during the study, but no quantitative investigation was introduced as no effect was suspected.
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # 20
- Organs examined: as outlined in OECD 414 guideline - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - External examinations: Yes: [all per litter]
- Soft tissue examinations: Yes: [half per litter]
- Skeletal examinations: Yes: [half per litter]
- Head examinations: Yes: [half per litter] - Statistics:
- The following statistical methods were used to analyze the data:
- If the variables could be assumed to follow a normal distribution, the Dunnett-test (Ref 6) (manyto-
one t-test) based on a pooled variance estimate was applied for the comparison of the treated
groups and the control groups for each sex.
- The Steel-test (Ref 7) (many-to-one rank test) was applied if the data could not be assumed to
follow a normal distribution.
- The Fisher Exact-test (Ref 8) was applied to frequency data.
- Mean litter proportions (percent per litter) of total fetal malformations and developmental external
variations, and each particular external malformation or variation were subjected to the Kruskal-
Wallis nonparametric ANOVA test (Ref 9) to determine intergroup differences. If the ANOVA
revealed statistically significant (p<0.05) intergroup variance. Dunn’s test (Ref 10) was used to
compare the compound-treated groups to the control group.
All tests were two-sided and in all cases p < 0.05 was accepted as the lowest level of significance.
Group means were calculated for continuous data and medians were calculated for discrete data
(scores) in the summary tables. Test statistics were calculated on the basis of exact values for means
and pooled variances. Individual values, means and standard deviations may be rounded off before
printing. Therefore, two groups may display the same printed means for a given parameter, yet display
different test statistics values. - Indices:
- The fetal developmental findings were summarized by: 1) presenting the incidence of a given finding both as the number of fetuses and the number of litters available for examination in the group; and 2) considering the litter as the basic unit for comparison, calculating the number of affected fetuses as
a mean litter proportion on a total group basis, where Viable fetuses affected/litter (%) = (number of viable fetuses affected/litter)/(number of viable fetuses/litter)x 100 - Historical control data:
- is available in the study report
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Details on maternal toxic effects:
Treatment with LIMUS-Sambaydestillation at 300 mg/kg body weight/day resulted in one unscheduled
death (killed in extremis), treatment-related clinical signs (lethargy, piloerection, hunched posture,
uncoordinated movements, abnormal gait, pale feces, pale and/or lean appearance), reduced body
weight/body weight gain and food consumption. At necropsy, no gross findings were noted that were
considered related to treatment.
No maternal toxicity was observed at the lower dose levels of 30 and 100 mg/kg body weight/day.
Effect levels (maternal animals)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 100 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- 100 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Details on embryotoxic / teratogenic effects:
There were no treatment-related effects on viability, litter size and sex ratio up to 300 mg/kg body
weight/day.
Reduced fetal body weights were noted for both male (statistical significant) and female (not
statistically significant) fetuses at 300 mg/kg body weight/day compared to controls. This adverse
effect on fetal body weight was considered related to the considerable maternal toxicity observed in
the high dose group. In line with this, both mean male and female placenta weights were slightly lower
at 300 mg/kg body weight/day compared to controls (not statistically significant).
Morphological examination of the fetuses revealed neither effects on fetal external or visceral
morphology nor skeletal malformations that could be related to treatment up to 300 mg/kg body
weight/day.
Several skeletal variations which were indicative for a developmental delay were noted at higher
incidences in the 300 mg/kg body weight/day group. These included reduced ossification of the skull,
unossified sternebra nos. 5 and/or 6, unossified hyoid, bipartite ossification of vertebral centra and
entire sternum unossified. In addition, the incidence of ossified cervical centrum no. 1 was decreased
at 300 mg/kg body weight/day compared to the concurrent control value. The reductions in ossification
noted were not statistically significant, but while considering the decreased fetal body weights at
300 mg/kg body weight/day, it is assumed that the delayed ossification occurred in this context.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.